Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
11 participants
OBSERVATIONAL
2020-11-01
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Corticosteroid Injections on Blood Glucose
NCT05048264
Dextrose Concentration Decline Rate in Vivo
NCT06128122
The Role of Proper Insulin Injection Technique in the Treatment of Diabetes Mellitus
NCT04120974
Systemic Effects of Epidural Methylprednisolone Injection on Glucose Tolerance in Diabetic Patients
NCT01420497
Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness
NCT00793741
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetic with Knee Osteoarthritis
HbA1c between 6.5% - 12.0% in the 3 months prior to Visit 1
40 mg Triamcinolone acetonide
Unilateral knee steroid injection
Pre-diabetic with Knee Osteoarthritis
HbA1c between 5.6% - 6.4% in the 3 months prior to Visit 1
40 mg Triamcinolone acetonide
Unilateral knee steroid injection
Non-diabetic with Knee Osteoarthritis
HbA1c \< 5.6% in the 3 months prior to Visit 1
40 mg Triamcinolone acetonide
Unilateral knee steroid injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
40 mg Triamcinolone acetonide
Unilateral knee steroid injection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indication for unilateral knee joint steroid injection for the treatment of knee joint osteoarthritis
Exclusion Criteria
* HbA1c \> 12.0%
* steroid exposure in the 3 months prior to Visit 1
* 3 or more steroid injections in the preceding 12 months
* known contraindication to steroid injection (adverse reaction or allergy, active infection, INR \> 3.0)
* lack of improvement with prior knee steroid injection
* change in diabetic medication regimen in the last 1 month
* significant change in diet within the last 1 month
* current use of aspirin
* allergy to adhesive
* planned MRI, XR, or CT during the 2-week study period
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Foundation for Physical Medicine and Rehabilitation
OTHER
University of Texas Southwestern Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Reed Williams
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Parkland Hospital
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU 2019-1202
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.